Highlights of the San Antonio Breast Cancer Symposium 2019 Part 2: the challenges of tumor heterogeneity

Benson, John R. and Dumitru, Dorin and Jatoi, Ismail (2020) Highlights of the San Antonio Breast Cancer Symposium 2019 Part 2: the challenges of tumor heterogeneity. Future Oncology, 16 (21). pp. 1503-1509. ISSN 1744-8301

[img] Text
Accepted Version
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (35kB)
Official URL: https://doi.org/10.2217/fon-2020-0310

Abstract

The 42nd annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio Texas on December 10 – 14, 2019. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, loco-regional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with the second part discussing a range of topics including extended hormonal therapy, capecitabine for partial responders after neoadjuvant chemotherapy (NACT), anti-HER2 therapies and immunotherapy with checkpoint inhibitors.

Item Type: Journal Article
Keywords: Extended hormone therapy, capecitabine, HER2 positive, immunotherapy, checkpoint inhibitors, San Antonio
Faculty: Faculty of Health, Education, Medicine & Social Care
Depositing User: Lisa Blanshard
Date Deposited: 30 Apr 2020 09:34
Last Modified: 29 May 2021 01:02
URI: https://arro.anglia.ac.uk/id/eprint/705458

Actions (login required)

Edit Item Edit Item